
Azhar Ali Khan
@drazharalikhan
Senior Clinical Fellow ISN, Renal Transplant, Royal Free London. Ex Consultant Nephrologist, Sheikh Zayed Hospital.
ID: 417264231
20-11-2011 18:42:12
2,2K Tweet
342 Followers
450 Following




Don’t you think he is more independent and unbiased journalist than you people. Respect demands honesty and credibility! Rauf Klasra Kamran Shahid Hamid Mir حامد میر Asma Shirazi Umar Cheema Gharidah Farooqi (T.I.) Mosharraf Zaidi 🍁









Great talk,FIDELITY analysis by Peter Rossing development of a risk score to predict hyperK in CKD patients. Risk of hyperK is greater e finerenone Vs placebo across increasing risk score categories but finerenone reduced CV & kidney outcomes irrespective of predicted hyperK groups



Emerging biological and targeted treatment in ANCA-associated vasculitis from Prof Annette Bruchfeld


On the sidelines of #ERA24 , always great to catch up with the people expert in their fields Adnan Sharif Jonathan Barratt


This year ERA 24 was amazing at Stockholm. Most number of publications presented during conference; FLOW in NEJM Sparsentan in FSGS in NEJM Sparsentan IgA in The Lancet Zenith CKD in The Lancet ENAKT-LD in JAMA Internal Medicine Anti-nephron podocytopathy blowing up MCD


